CROSSROADS STRATEGIES, LLC for INTELLIA THERAPEUTICS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and advocacy related to genome editing technology. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019. H.R.1425, Patient Protection and Affordable Care Enhancement Act. FY2021 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.7614), FY2021 Consolidated Appropriations Act (H.R.7617), H.R.8337, Continuing Appropriations Act, 2021 and Other Extensions Act. H.R.133, Making consolidated appropriations for the fiscal year ending September 30, 2021, providing coronavirus emergency response and relief, and for other purposes (P.L.116-260).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHERINE DAPPER | — |
| JASON GLEASON | — |
| SHAY MICHAEL HANCOCK | — |
| MATHEW LAPINSKI | — |
| MARC NUMEDAHL | — |
| JASON BENJAMIN VAN PELT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.